Alnylam Pharmaceuticals Company Profile

Aggregated data from the web about Alnylam Pharmaceuticals

Company Name	Alnylam Pharmaceuticals
Website	https://www.alnylam.com
Snippet	Our Company. THE LEADING RNAi THERAPEUTICS COMPANY. Alnylam has led the translation of RNA interference (RNAi) from Nobel Prize-winning discovery into an entirely new class of …
Type	Public
Founded	2002
Revenue	US $219.75 million (2019) US $74.91 million (2018)[1]
Website	alnylam.com
Industry	Pharmaceutical
Traded as	Nasdaq: ALNYRussell 1000 Component
Key people	John Maraganore, (CEO)
Headquarters	Cambridge, Massachusetts, US
Number of employees	1,323 (2019)[2]

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.